Stella Pharma Corporation (4888.T)
- Previous Close
290.00 - Open
290.00 - Bid 292.00 x --
- Ask 294.00 x --
- Day's Range
286.00 - 295.00 - 52 Week Range
229.00 - 366.00 - Volume
43,700 - Avg. Volume
169,296 - Market Cap (intraday)
9.118B - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
-- - EPS (TTM)
-25.32 - Earnings Date May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.
www.stella-pharma.co.jpRelated News
Performance Overview: 4888.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4888.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4888.T
Valuation Measures
Market Cap
9.12B
Enterprise Value
7.53B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
35.88
Price/Book (mrq)
3.41
Enterprise Value/Revenue
29.64
Enterprise Value/EBITDA
-9.90
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.06%
Return on Equity (ttm)
-28.94%
Revenue (ttm)
254M
Net Income Avi to Common (ttm)
-764M
Diluted EPS (ttm)
-25.32
Balance Sheet and Cash Flow
Total Cash (mrq)
2.56B
Total Debt/Equity (mrq)
36.44%
Levered Free Cash Flow (ttm)
--
Company Insights: 4888.T
4888.T does not have Company Insights